Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

by Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group
Published 2021-02-01

Machine learning to assist clinical decision-making during the COVID-19 pandemic

by Shubham Debnath, Douglas P. Barnaby, Kevin Coppa, Alexander Makhnevich, Eun Ji Kim, Saurav Chatterjee, Viktor Tóth, Todd J. Levy, Marc d. Paradis, Stuart L. Cohen, Jamie S. Hirsch, Theodoros P. Zanos, the Northwell COVID-19 Research Consortium
Published 2020-07-01

Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York

by Martin Lesser, Kevin Coppa, Jamie S Hirsch, Sara Abrahams, Jennifer Johnson, Karina W Davidson, Stuart L Cohen, Stephen C Machnicki, Alex Makhnevich, Prashant Malhotra, Lyndonna Marrast, Ramanak Mitra, Ernesto P Molmenti, M Wasif Saif, Sanjaya Satapathy, Shalin Shah
Published 2021-02-01